ADIPOQ and obesity disorder: In contrast, adiponectin, an anti-inflammatory adipokine, decreased in obesity, acts as an insulin-sensitizing hormone in muscles and the liver; low levels of adiponectin contribute to peripheral insulin resistance [71].